• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Merck Serono LTD, Israel


    Drugs Disributed by Merck Serono LTD, Israel

    Crinone 8%
    Merck Serono LTD, Israel
    RX
    partial basket chart
    Crinone 8%

    Progestogen. Progesterone 8% w/w.
    Sgle. use prefill. vag. gel applic.:6,15 X1.125 g. Infert. due to inad. luteal phase: 1 applic/day start. after docum. ovul. or arbitr. on the 18th-21st-day of the cycle. For in- vitro fertil., when infertil. is due to tubal, idiopathic or endometriosis linked steril. assoc. with normal cycles: 1 app/day for 30 days if there is lab evid. of pregn. Infert. due to inadeq. luteal phase. In- vitro fertil., when infertil. is due to tubal, idiopathic,or endometriosis linked steril. assoc. with normal cycles.
    C/I:Hypersens, Undiagn. vag. bleeding. Known or susp. progest.-sensit. malign. tumors. Porphyria. Thrombophleb., thromboembolic dis, cereb. apoplexy, or pts. with an history of these condit. Missed abort.

    Mavenclad
    Merck Serono LTD, Israel
    RX
    partial basket chart
    Mavenclad

    Immunosuppressant. Cladribine 10 mg.
    Tab: 1/4/6X 10 mg: 3.5 mg/kg bw over 2 years,  admin. as 1 tmt. course of 1.75 mg/kg per year. Tmt. course consists of 2 tmt. weeks, one at the beginn. of the first month and one at the beginn. of the sec. month of the respect. tmt. year. See prescr. info.
    Tmt. of adlt. pts. with high. act. relaps. multiple sclerosis (MS) as by clinical or imaging features
    C/I: Hypersens.
    HIV.
    Act. chron. infect. (tuberculosis or hepatitis).
    Init. of this tmt. in immunocomprom. pts, incl. pts. on
    immunosuppr. or myelosuppr. ther. (See prescr. info).
    Act. malign.
    Mod. or sev. renal impair. (creat. clear. <60 mL/min) (See prescr. info).
    Pregn. and breast-feed.

    Tepmetko
    Merck Serono LTD, Israel
    RX
    partial basket chart
    Tepmetko

    Protein Kinase Inhibitor. Tepotinib (as hydrochloride hydrate) 225 mg.
    FC tabs:60 Two tabs, once/day
    Tmt. of adlt pts. with metastatic non-small cell lung
    cancer (NSCLC) harbouring a MET tyrosine kinase receptor exon 14 (METex14) skip. mut.
    C/I:Hypersens., see prescr. info. for full details.

    CLOSE